| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |